Copyright Reports & Markets. All rights reserved.

Global Genomics In Cancer Care Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Genomics In Cancer Care Market Overview

    • 1.1 Product Overview and Scope of Genomics In Cancer Care
    • 1.2 Classification of Genomics In Cancer Care by Type
      • 1.2.1 Global Genomics In Cancer Care Revenue by Type: 2015 VS 2019 VS 2025
      • 1.2.2 Global Genomics In Cancer Care Revenue Market Share by Type in 2019
      • 1.2.3 Instruments
      • 1.2.4 Consumables
      • 1.2.5 Services
    • 1.3 Global Genomics In Cancer Care Market by Application
      • 1.3.1 Overview: Global Genomics In Cancer Care Revenue by Application: 2015 VS 2019 VS 2025
      • 1.3.2 Diagnostics
      • 1.3.3 Personalized Medicine
      • 1.3.4 Drug Discovery
      • 1.3.5 Development
      • 1.3.6 Research
    • 1.4 Global Genomics In Cancer Care Market by Regions
      • 1.4.1 Global Genomics In Cancer Care Market Size by Regions: 2015 VS 2019 VS 2025
      • 1.4.2 Global Market Size of Genomics In Cancer Care (2015-2025)
      • 1.4.3 North America (USA, Canada and Mexico) Genomics In Cancer Care Status and Prospect (2015-2025)
      • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Genomics In Cancer Care Status and Prospect (2015-2025)
      • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Genomics In Cancer Care Status and Prospect (2015-2025)
      • 1.4.6 South America (Brazil, Argentina, Colombia) Genomics In Cancer Care Status and Prospect (2015-2025)
      • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Genomics In Cancer Care Status and Prospect (2015-2025)

    2 Company Profiles

    • 2.1 Illumina
      • 2.1.1 Illumina Details
      • 2.1.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.1.3 Illumina SWOT Analysis
      • 2.1.4 Illumina Product and Services
      • 2.1.5 Illumina Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
    • 2.2 Danaher
      • 2.2.1 Danaher Details
      • 2.2.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.2.3 Danaher SWOT Analysis
      • 2.2.4 Danaher Product and Services
      • 2.2.5 Danaher Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
    • 2.3 Roche
      • 2.3.1 Roche Details
      • 2.3.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.3.3 Roche SWOT Analysis
      • 2.3.4 Roche Product and Services
      • 2.3.5 Roche Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
    • 2.4 Thermo Fisher scientific
      • 2.4.1 Thermo Fisher scientific Details
      • 2.4.2 Thermo Fisher scientific Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.4.3 Thermo Fisher scientific SWOT Analysis
      • 2.4.4 Thermo Fisher scientific Product and Services
      • 2.4.5 Thermo Fisher scientific Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
    • 2.5 Bio-Rad
      • 2.5.1 Bio-Rad Details
      • 2.5.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.5.3 Bio-Rad SWOT Analysis
      • 2.5.4 Bio-Rad Product and Services
      • 2.5.5 Bio-Rad Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
    • 2.6 Agilent
      • 2.6.1 Agilent Details
      • 2.6.2 Agilent Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.6.3 Agilent SWOT Analysis
      • 2.6.4 Agilent Product and Services
      • 2.6.5 Agilent Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
    • 2.7 Pacific Biosciences
      • 2.7.1 Pacific Biosciences Details
      • 2.7.2 Pacific Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.7.3 Pacific Biosciences SWOT Analysis
      • 2.7.4 Pacific Biosciences Product and Services
      • 2.7.5 Pacific Biosciences Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
    • 2.8 Beckman Coulter
      • 2.8.1 Beckman Coulter Details
      • 2.8.2 Beckman Coulter Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.8.3 Beckman Coulter SWOT Analysis
      • 2.8.4 Beckman Coulter Product and Services
      • 2.8.5 Beckman Coulter Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
    • 2.9 Cancer Genetics
      • 2.9.1 Cancer Genetics Details
      • 2.9.2 Cancer Genetics Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.9.3 Cancer Genetics SWOT Analysis
      • 2.9.4 Cancer Genetics Product and Services
      • 2.9.5 Cancer Genetics Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
    • 2.10 Sigma Aldrich
      • 2.10.1 Sigma Aldrich Details
      • 2.10.2 Sigma Aldrich Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.10.3 Sigma Aldrich SWOT Analysis
      • 2.10.4 Sigma Aldrich Product and Services
      • 2.10.5 Sigma Aldrich Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
    • 2.11 Qiagen
      • 2.11.1 Qiagen Details
      • 2.11.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.11.3 Qiagen SWOT Analysis
      • 2.11.4 Qiagen Product and Services
      • 2.11.5 Qiagen Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
    • 2.12 Quest Diagnostics
      • 2.12.1 Quest Diagnostics Details
      • 2.12.2 Quest Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.12.3 Quest Diagnostics SWOT Analysis
      • 2.12.4 Quest Diagnostics Product and Services
      • 2.12.5 Quest Diagnostics Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
    • 2.13 GE Healthcare
      • 2.13.1 GE Healthcare Details
      • 2.13.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.13.3 GE Healthcare SWOT Analysis
      • 2.13.4 GE Healthcare Product and Services
      • 2.13.5 GE Healthcare Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
    • 2.14 PerkinElmer
      • 2.14.1 PerkinElmer Details
      • 2.14.2 PerkinElmer Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.14.3 PerkinElmer SWOT Analysis
      • 2.14.4 PerkinElmer Product and Services
      • 2.14.5 PerkinElmer Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
    • 2.15 Luminex
      • 2.15.1 Luminex Details
      • 2.15.2 Luminex Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.15.3 Luminex SWOT Analysis
      • 2.15.4 Luminex Product and Services
      • 2.15.5 Luminex Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
    • 2.16 Thermo Fisher scientific
      • 2.16.1 Thermo Fisher scientific Details
      • 2.16.2 Thermo Fisher scientific Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.16.3 Thermo Fisher scientific SWOT Analysis
      • 2.16.4 Thermo Fisher scientific Product and Services
      • 2.16.5 Thermo Fisher scientific Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
    • 2.17 Oxford Gene Technology
      • 2.17.1 Oxford Gene Technology Details
      • 2.17.2 Oxford Gene Technology Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.17.3 Oxford Gene Technology SWOT Analysis
      • 2.17.4 Oxford Gene Technology Product and Services
      • 2.17.5 Oxford Gene Technology Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)

    3 Market Competition, by Players

    • 3.1 Global Genomics In Cancer Care Revenue and Share by Players (2015-2020)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Genomics In Cancer Care Players Market Share
      • 3.2.2 Top 10 Genomics In Cancer Care Players Market Share
    • 3.3 Market Competition Trend

    4 Market Size by Regions

    • 4.1 Global Genomics In Cancer Care Revenue and Market Share by Regions
    • 4.2 North America Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
    • 4.3 Europe Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
    • 4.4 Asia-Pacific Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
    • 4.5 South America Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
    • 4.6 Middle East & Africa Genomics In Cancer Care Revenue and Growth Rate (2015-2020)

    5 North America Genomics In Cancer Care Revenue by Countries

    • 5.1 North America Genomics In Cancer Care Revenue by Countries (2015-2020)
    • 5.2 USA Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
    • 5.3 Canada Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
    • 5.4 Mexico Genomics In Cancer Care Revenue and Growth Rate (2015-2020)

    6 Europe Genomics In Cancer Care Revenue by Countries

    • 6.1 Europe Genomics In Cancer Care Revenue by Countries (2015-2020)
    • 6.2 Germany Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
    • 6.3 UK Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
    • 6.4 France Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
    • 6.5 Russia Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
    • 6.6 Italy Genomics In Cancer Care Revenue and Growth Rate (2015-2020)

    7 Asia-Pacific Genomics In Cancer Care Revenue by Countries

    • 7.1 Asia-Pacific Genomics In Cancer Care Revenue by Countries (2015-2020)
    • 7.2 China Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
    • 7.3 Japan Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
    • 7.4 Korea Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
    • 7.5 India Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
    • 7.6 Southeast Asia Genomics In Cancer Care Revenue and Growth Rate (2015-2020)

    8 South America Genomics In Cancer Care Revenue by Countries

    • 8.1 South America Genomics In Cancer Care Revenue by Countries (2015-2020)
    • 8.2 Brazil Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
    • 8.3 Argentina Genomics In Cancer Care Revenue and Growth Rate (2015-2020)

    9 Middle East & Africa Revenue Genomics In Cancer Care by Countries

    • 9.1 Middle East & Africa Genomics In Cancer Care Revenue by Countries (2015-2020)
    • 9.2 Saudi Arabia Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
    • 9.3 UAE Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
    • 9.4 Egypt Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
    • 9.5 South Africa Genomics In Cancer Care Revenue and Growth Rate (2015-2020)

    10 Market Size Segment by Type

    • 10.1 Global Genomics In Cancer Care Revenue and Market Share by Type (2015-2020)
    • 10.2 Global Genomics In Cancer Care Market Forecast by Type (2019-2024)
    • 10.3 Instruments Revenue Growth Rate (2015-2025)
    • 10.4 Consumables Revenue Growth Rate (2015-2025)
    • 10.5 Services Revenue Growth Rate (2015-2025)

    11 Global Genomics In Cancer Care Market Segment by Application

    • 11.1 Global Genomics In Cancer Care Revenue Market Share by Application (2015-2020)
    • 11.2 Genomics In Cancer Care Market Forecast by Application (2019-2024)
    • 11.3 Diagnostics Revenue Growth (2015-2020)
    • 11.4 Personalized Medicine Revenue Growth (2015-2020)
    • 11.5 Drug Discovery Revenue Growth (2015-2020)
    • 11.6 Development Revenue Growth (2015-2020)
    • 11.7 Research Revenue Growth (2015-2020)

    12 Global Genomics In Cancer Care Market Size Forecast (2021-2025)

    • 12.1 Global Genomics In Cancer Care Market Size Forecast (2021-2025)
    • 12.2 Global Genomics In Cancer Care Market Forecast by Regions (2021-2025)
    • 12.3 North America Genomics In Cancer Care Revenue Market Forecast (2021-2025)
    • 12.4 Europe Genomics In Cancer Care Revenue Market Forecast (2021-2025)
    • 12.5 Asia-Pacific Genomics In Cancer Care Revenue Market Forecast (2021-2025)
    • 12.6 South America Genomics In Cancer Care Revenue Market Forecast (2021-2025)
    • 12.7 Middle East & Africa Genomics In Cancer Care Revenue Market Forecast (2021-2025)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology
      • 14.2 Data Source
      • 14.3 Disclaimer

      Market Overview
      The global Genomics In Cancer Care market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.4% in the forecast period of 2020 to 2025 and will expected to reach USD 22870 million by 2025, from USD 15970 million in 2019.

      The Genomics In Cancer Care market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

      Market segmentation
      Genomics In Cancer Care market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

      By Type, Genomics In Cancer Care market has been segmented into:
      Instruments
      Consumables
      Services

      By Application, Genomics In Cancer Care has been segmented into:
      Diagnostics
      Personalized Medicine
      Drug Discovery
      Development
      Research

      Regions and Countries Level Analysis
      Regional analysis is another highly comprehensive part of the research and analysis study of the global Genomics In Cancer Care market presented in the report. This section sheds light on the sales growth of different regional and country-level Genomics In Cancer Care markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Genomics In Cancer Care market.

      The report offers in-depth assessment of the growth and other aspects of the Genomics In Cancer Care market in important countries (regions), including:
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Competitive Landscape and Genomics In Cancer Care Market Share Analysis
      Genomics In Cancer Care competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Genomics In Cancer Care sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Genomics In Cancer Care sales, revenue and market share for each player covered in this report.

      The major players covered in Genomics In Cancer Care are:
      Illumina
      Danaher
      Roche
      Thermo Fisher scientific
      Bio-Rad
      Agilent
      Pacific Biosciences
      Beckman Coulter
      Cancer Genetics
      Sigma Aldrich
      Qiagen
      Quest Diagnostics
      GE Healthcare
      PerkinElmer
      Luminex
      Thermo Fisher scientific
      Oxford Gene Technology

      Buy now